Roche Ag (OTC: RHHBY)
Roche Ag Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Roche Ag Company Info
Roche Holding AG is a research healthcare company. It operates through the Pharmaceuticals and Diagnostics segments. The Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
News & Analysis
Why Roche Holdings Stock Popped Today
Roche's new Alzheimer's test has a long road ahead of it, but it may help boost the pharmaceutical company's slow growth rate.
Investing in Blue Chip ETFs
An in-depth look at the leading blue chip stock ETFs in the U.S stock market this year.
This Big Pharma Is Teaming Up With Nvidia to Make Drugs With AI. Here's What You Need to Know
It isn't the first drugmaker to partner with the chipmaker, and it won't be the last.
ESG Funds for Responsible Investors
You really can build a high-performing portfolio that advances sustainability initiatives.
Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?
The three companies are spending big on IBD therapies.
Roche's Slow Growth Shouldn't Drive Investors Away
New treatments for various cancers, eye diseases, and more may bring in future revenues.
Is Roche a Buy Now?
Roche focuses on the long-term.
Better Large-Cap Buy: Roche Holding or Gilead Sciences Stock?
Which of these companies is better able to replace declining COVID-19-related sales?
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.